Axcelis [ACLS] vs Onto Innovation [ONTO] Detailed Stock Comparison
Axcelis
NASDAQ
Loading...
Onto Innovation
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Axcelis wins in 10 metrics, Onto Innovation wins in 9 metrics, with 0 ties. Axcelis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Axcelis | Onto Innovation | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.43 | 26.62 | Axcelis |
| Price-to-Book Ratio | 2.47 | 2.68 | Axcelis |
| Debt-to-Equity Ratio | 7.04 | 0.68 | Onto Innovation |
| PEG Ratio | -0.45 | -0.75 | Onto Innovation |
| EV/EBITDA | 12.09 | 16.53 | Axcelis |
| Profit Margin (TTM) | 17.69% | 19.29% | Onto Innovation |
| Operating Margin (TTM) | 14.89% | 19.10% | Onto Innovation |
| EBITDA Margin (TTM) | 14.89% | 19.10% | Onto Innovation |
| Return on Equity | 16.19% | 10.53% | Axcelis |
| Return on Assets (TTM) | 7.64% | 6.31% | Axcelis |
| Free Cash Flow (TTM) | $128.64M | $213.77M | Onto Innovation |
| 1-Year Return | -31.26% | -50.48% | Axcelis |
| Price-to-Sales Ratio (TTM) | 2.82 | 5.09 | Axcelis |
| Enterprise Value | $2.05B | $4.39B | Onto Innovation |
| EV/Revenue Ratio | 2.29 | 4.24 | Axcelis |
| Gross Profit Margin (TTM) | 44.90% | 48.16% | Onto Innovation |
| Revenue per Share (TTM) | $28 | $21 | Axcelis |
| Earnings per Share (Diluted) | $4.90 | $4.04 | Axcelis |
| Beta (Stock Volatility) | 1.57 | 1.44 | Onto Innovation |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Axcelis vs Onto Innovation Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Axcelis | -0.71% | -6.27% | 5.33% | 32.91% | 24.40% | 11.84% |
| Onto Innovation | -0.44% | -4.15% | 5.84% | 11.46% | -33.86% | -38.48% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Axcelis | -31.26% | 8.60% | 225.36% | 519.16% | 1,244.35% | 234.94% |
| Onto Innovation | -50.48% | 38.54% | 229.36% | 220.26% | 220.26% | 220.26% |
Performance & Financial Health Analysis: Axcelis vs Onto Innovation
| Metric | ACLS | ONTO |
|---|---|---|
| Market Information | ||
| Market Cap | $2.53B | $5.27B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 715,290 | 1,851,590 |
| 90 Day Avg. Volume | 533,553 | 1,331,770 |
| Last Close | $78.51 | $105.46 |
| 52 Week Range | $40.40 - $117.09 | $85.88 - $228.42 |
| % from 52W High | -32.95% | -53.83% |
| All-Time High | $201.00 (Jul 31, 2023) | $238.93 (Jul 15, 2024) |
| % from All-Time High | -60.94% | -55.86% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.24% | 0.05% |
| Quarterly Earnings Growth | -0.38% | -0.36% |
| Financial Health | ||
| Profit Margin (TTM) | 0.18% | 0.19% |
| Operating Margin (TTM) | 0.15% | 0.19% |
| Return on Equity (TTM) | 0.16% | 0.11% |
| Debt to Equity (MRQ) | 7.04 | 0.68 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $32.54 | $40.12 |
| Cash per Share (MRQ) | $17.50 | $18.26 |
| Operating Cash Flow (TTM) | $138.05M | $273.17M |
| Levered Free Cash Flow (TTM) | $67.30M | $187.12M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Axcelis vs Onto Innovation
| Metric | ACLS | ONTO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.43 | 26.62 |
| Forward P/E | 14.88 | 16.03 |
| PEG Ratio | -0.45 | -0.75 |
| Price to Sales (TTM) | 2.82 | 5.09 |
| Price to Book (MRQ) | 2.47 | 2.68 |
| Market Capitalization | ||
| Market Capitalization | $2.53B | $5.27B |
| Enterprise Value | $2.05B | $4.39B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.29 | 4.24 |
| Enterprise to EBITDA | 12.09 | 16.53 |
| Risk & Other Metrics | ||
| Beta | 1.57 | 1.44 |
| Book Value per Share (MRQ) | $32.54 | $40.12 |
Financial Statements Comparison: Axcelis vs Onto Innovation
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ACLS | ONTO |
|---|---|---|
| Revenue/Sales | $194.54M | $253.60M |
| Cost of Goods Sold | $107.20M | $131.48M |
| Gross Profit | $87.34M | $122.12M |
| Research & Development | $27.06M | $35.29M |
| Operating Income (EBIT) | $28.97M | $38.47M |
| EBITDA | $40.87M | $60.13M |
| Pre-Tax Income | $35.00M | $39.74M |
| Income Tax | $3.62M | $5.83M |
| Net Income (Profit) | $31.38M | $33.91M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ACLS | ONTO |
|---|---|---|
| Cash & Equivalents | $183.96M | $203.73M |
| Total Current Assets | $1.11B | $1.47B |
| Total Current Liabilities | $200.37M | $174.48M |
| Long-Term Debt | $41.96M | $8.66M |
| Total Shareholders Equity | $1.03B | $1.92B |
| Retained Earnings | $485.67M | $671.12M |
| Property, Plant & Equipment | $100.83M | $13.49M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ACLS | ONTO |
|---|---|---|
| Operating Cash Flow | $39.11M | $81.15M |
| Capital Expenditures | N/A | $-8.23M |
| Free Cash Flow | $34.84M | $83.75M |
| Debt Repayment | $-349,000 | N/A |
| Common Stock Repurchase | $-18.18M | $-75.02M |
Short Interest & Institutional Ownership Analysis
| Metric | ACLS | ONTO |
|---|---|---|
| Shares Short | 5.28M | 2.12M |
| Short Ratio | 12.17 | 2.06 |
| Short % of Float | 0.25% | 0.06% |
| Average Daily Volume (10 Day) | 715,290 | 1,851,590 |
| Average Daily Volume (90 Day) | 533,553 | 1,331,770 |
| Shares Outstanding | 32.37M | 49.24M |
| Float Shares | 31.25M | 48.60M |
| % Held by Insiders | 0.02% | 0.01% |
| % Held by Institutions | 1.07% | 1.03% |
Dividend Analysis & Yield Comparison: Axcelis vs Onto Innovation
| Metric | ACLS | ONTO |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |